• Cholecystokinin Octapeptide Ammonium: Protocols & Innovation

  2026-06-29

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) is an essential tool for dissecting brain–gut peptide signaling, with unique advantages in behavioral, immunological, and neuroapoptotic assays. This article details advanced workflows, troubleshooting strategies, and translational insights that leverage CCK-8 ammonium’s context-specific activity.

• Cyanine 3-dCTP: Unlocking Precision Fluorescent DNA Labeling

  2026-06-28

  Explore how Cy3-dCTP (Cyanine 3-deoxycytidine triphosphate) advances direct enzymatic labeling of DNA and cDNA, powered by insights from highly ordered DNA frameworks. This article delivers a unique, research-driven analysis of Cy3-dCTP’s role in robust, multiplexed molecular assays.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Fluorescence Amplif

  2026-06-27

  The Cy5 Goat Anti-Rabbit IgG (H+L) Antibody empowers sensitive, multiplexed fluorescence detection in immunohistochemistry and related immunoassays, offering robust signal amplification with minimal cross-reactivity. Its optimized formulation and high-affinity Cy5 conjugation make it indispensable for unraveling complex antiviral signaling pathways.

• Metoprolol as a Selective Beta1-Adrenoceptor Antagonist: App

  2026-06-26

  Metoprolol’s unique selectivity and validated activity make it a cornerstone for research into cardiovascular, anti-inflammatory, and tumor biology pathways. This article demystifies advanced workflows, experimental enhancements, and troubleshooting strategies with APExBIO’s rigorously characterized Metoprolol, bridging new insights from PK variability studies to optimize preclinical model design.

• ATM Inhibition and Fenofibrate Synergy in Ovarian Cancer Cel

  2026-06-26

  This study demonstrates that inhibiting ATM kinase, in combination with the metabolic drug fenofibrate, synergistically induces senescence in high grade serous ovarian cancer (HGSOC) cells. The findings highlight a metabolic vulnerability in HR-proficient HGSOC, suggesting alternative therapeutic avenues for patients unresponsive to current DNA repair-targeted therapies.

• Tetrazolium (chloride): Redefining Mitochondrial and Tissue

  2026-06-25

  Explore how Tetrazolium (chloride) advances mitochondrial function and tissue viability assays, with a deep dive into its mechanism, protocol optimization, and translational impact in ischemic injury research. Discover unique insights and expert strategies for reliable assay design.

• Protease Inhibitor Cocktail (100X in DMSO, EDTA plus): Workf

  2026-06-25

  Preserving protein integrity is critical in cell viability and cytotoxicity assays. This article addresses real-world laboratory challenges and demonstrates how 'Protease Inhibitor Cocktail (100X in DMSO, EDTA plus)' (SKU K1019) delivers robust, reproducible results in demanding workflows. Evidence-based scenarios reveal its practical value for biomedical researchers and postgraduates.

• iRhom2 Orchestrates Olfactory Receptor Adaptation in Neurons

  2026-06-24

  Azzopardi et al. (2024) uncover a unique regulatory role for iRhom2 in mouse olfactory sensory neurons, delineating its involvement in activity-dependent adaptation of olfactory receptor (OR) gene expression. This work provides novel mechanistic insights into odor-driven feedback and the iRhom2/ADAM17 pathway, with broader implications for sensory plasticity research.

• Nicotinamide Adenine Dinucleotide (NAD+): Molecular Gatekeep

  2026-06-23

  Explore the pivotal role of Nicotinamide Adenine Dinucleotide (NAD+) as a molecular integrator of stress adaptation and DNA repair. This article offers a comprehensive, mechanism-focused analysis distinct from protocol-centric guides, revealing new insights for advanced metabolic and cancer research.

• Technical Guide: Angiotensin I/II (1-5) in RAS Workflows

  2026-06-23

  Angiotensin I/II (1-5) addresses the need for a defined Asp-Arg-Val-Tyr-Ile peptide fragment in renin-angiotensin system research, specifically for assays on blood pressure regulation and aldosterone signaling. Its use is limited to cardiovascular and renal workflows, and careful attention to solubility and storage is essential for reproducibility.

• Estradiol–Autophagy Axis: Organ Protection in Perimenopausal

  2026-06-22

  This study reveals how declining estradiol during perimenopause increases the risk for cardiovascular, renal, and metabolic disease by disrupting estrogen receptor–mediated autophagy. Through integrated human cohort data, network pharmacology, and mouse models, the authors demonstrate that estrogen replacement exerts organ-protective effects via ERα/ERβ signaling and autophagy activation, providing mechanistic insight for precision hormone therapies.

• Lactate-GPR81/FARP1 Pathway Enables Insulin-Independent Gluc

  2026-06-22

  The referenced study uncovers a lactate-activated GPR81/FARP1 signaling axis that promotes glucose uptake in skeletal muscle independently of insulin, redefining our understanding of metabolic regulation. This finding highlights new therapeutic opportunities for metabolic disease intervention that go beyond traditional insulin-centric approaches.

• Carvacrol (5-Isopropyl-2-Methylphenol) in Cell Cycle & TRP R

  2026-06-21

  Carvacrol empowers cell cycle, apoptosis, and redox signaling studies by bridging TRP channel pharmacology with oxidative stress biology. This article translates cutting-edge findings into actionable workflows, highlighting APExBIO’s Carvacrol as an optimal reagent for advanced experimental design.

• Intestinal TM6SF2 Regulation of Gut–Liver Axis in MASH Patho

  2026-06-20

  This study reveals that intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and modulating lipid and immune signaling through the gut–liver axis. Mechanistic insights connect TM6SF2 loss to microbial dysbiosis and lysophosphatidic acid (LPA) elevation, identifying new intervention points for metabolic liver disease.

• Tiamulin (Thiamutilin): Optimized Workflows for Veterinary U

  2026-06-19

  Tiamulin (Thiamutilin) stands out as a dual-action pleuromutilin antibiotic, exerting both antibacterial and anti-inflammatory effects for advanced veterinary research. This article delivers stepwise protocols, troubleshooting strategies, and translational insights for maximizing experimental impact in infectious disease control and immunomodulation studies.

449 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page